IFM Therapeutics Acquired by Bristol-Myers Squibb

Posted by ISPE Boston
On August 17, 2017

Bristol-Myers Squibb (BMS) has agreed to pay $300 million to acquire Cambridge-based IFM Therapeutics, a venture-backed startup founded in 2015 focused on innate immunity and the role it plays in regulating the immune system. IFM’s team has discovered and developed small molecules that modulate novel targets in the innate immune system as next-generation therapies for […]

Student Chapters Need Your Help to Meet Goals for 2017-18

Posted by Brian Hagopian
On August 16, 2017

The Chapter’s Student Development Committee held a strategic planning meeting in early August to review progress and plot a strategic direction for the upcoming year. This annual event brings together student leaders, faculty advisors, committee members and other interested volunteers to brainstorm ways to strengthen support for our Student Chapters, which now number 13 throughout […]

Welcome New Members!

Posted by ISPE Boston
On August 15, 2017

The following members joined ISPE in July 2017. We welcome you to the Chapter and encourage you to take advantage of the many professional development, networking and information resources available to you at ISPE. Other ISPE members are a terrific resource for your everyday professional challenges – we encourage all members, current and new, to […]

Chapter Member Anniversaries: July 2017

Posted by ISPE Boston
On August 15, 2017

Please congratulate the following members celebrating milestone anniversaries in July 2017. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Shelly Henderson Jose Miguel Soto, Facility and Equipment Lead, Pfizer Inc Dr. James V. Blackwell, PhD, MBA, President, The Windshire Group, LLC Nicholas J. Casale, Vice President, MA […]

Success and Succession

Posted by John Spohn
On July 26, 2017

It is with gratitude and humility that I write this post marking the end of my term as Chapter President. Leading the largest Chapter through a year of surpassing excellence has taught me much and left me in awe of what can be accomplished by committed, well-organized volunteers. Some numbers: 1,700 members, spread over 80,000 […]

Student Members Earn Chapter Scholarships

Posted by Janet Tice
On July 26, 2017

The Chapter is proud to award $12,500 in scholarships to the following winners of the June 2017 round of the Joel Goldenberg Memorial Scholarship Program: Adam Blackwell, UMass Amherst John de la Parra, Northeastern University Michael Doane, UMass Lowell Chelsea Fox, University of Rhode Island Jamie Freud, Worcester Polytechnic Institute Daniel Kallin, UMass Amherst Aislinn […]

YPs Cheer On the Sox at Fenway

Posted by Brian Kennedy
On July 25, 2017

The Boston Area Young Professionals held their annual Red Sox summer outing on Monday, July 17th. Over 40 biotech and pharma professionals of all ages gathered before the game at Bullpen Kitchen + Tap (formerly known as Who’s on First) to socialize, eat some great food and, most importantly, collect their Sox tickets! Win or […]

Avecia Expanding Drug Manufacturing Facility in Milford

Posted by ispeblog
On July 19, 2017

Avecia, a pharmaceutical manufacturer in Milford, says it is building what will become the largest manufacturing site in the world for a specialized drug ingredient called oligonucleotide. The expansion, which will add 20,000 square feet of space, will more than double the Milford site’s total capacity, the company said in a recent announcement. Oligonucleotide, a […]

MassBioEd Predicts Job Trends Forecast for the Biopharma Industry

Posted by ispeblog
On July 19, 2017

The MassBioEd Foundation released its 2017 Annual Job Trends Forecast at Life Sciences Workforce 2017, its second annual conference on life sciences workforce trends. The event was held at Northeastern University and featured twenty-seven industry and higher education speakers, as well as Lt. Governor Karyn Polito, who provided keynote remarks. The Forecast included the following […]

Novartis Gene Therapy Recommended for Approval by FDA Advisory Committee

Posted by ispeblog
On July 17, 2017

Novartis has announced that the FDA Oncologic Drugs Advisory Committee (ODAC) unanimously (10-0) recommended approval of CTL019 (tisagenlecleucel), an investigational chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of children and young adults with B-cell acute lymphoblastic leukemia (ALL) that has relapsed or resisted treatment (r/r). A Biologics License Application (BLA) for this […]

Page 109 of 117«‹107 108109110 111 ›»